Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
Abstract Background Acquired resistance remains a limitation of the clinical use of 5-fluorouracil (5-FU). Because exosomes, are important vesicles participating in intercellular communication, their contribution to the development of acquired 5-FU resistance needs to be elucidated. In this study, w...
Main Authors: | Qian Zhang, Rui-Xian Liu, Ka-Wo Chan, Jiancong Hu, Jingdan Zhang, Lili Wei, Huiliu Tan, Xiangling Yang, Huanliang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1314-9 |
Similar Items
-
Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer
by: Zhu Y, et al.
Published: (2020-11-01) -
NHE1 Mediates 5-Fu Resistance in Gastric Cancer via STAT3 Signaling Pathway
by: Sun Z, et al.
Published: (2020-08-01) -
Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis
by: Mónica G. Mendoza-Rodríguez, et al.
Published: (2020-03-01) -
Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
by: Xianjun Sun, et al.
Published: (2020-12-01) -
DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance
by: Pan Xie, et al.
Published: (2021-05-01)